Advanced in Herpes Simplex Encephalitis

Andrea A. Assanelli

Milan, IT 
Advanced in Herpes Simplex Encephalitis
Milan, IT 
OverviewLocationsClinical Research

Overview

Andrea Assanelli practices in Milan, Italy. Ms. Assanelli is rated as an Advanced expert by MediFind in the treatment of Herpes Simplex Encephalitis. Her top areas of expertise are Graft Versus Host Disease (GvHD), Febrile Neutropenia, Agranulocytosis, Bone Marrow Transplant, and Bone Graft.

Her clinical research consists of co-authoring 64 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Female

Locations

Milan, Italy
Other Locations
San Raffaele, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

High-dose Sequential Chemotherapy and Rituximab (R-HDS) in Patients With Systemic B-cell Lymphoma With Central Nervous System Involvement at Diagnosis or Relapse
High-dose Sequential Chemotherapy and Rituximab (R-HDS) in Patients With Systemic B-cell Lymphoma With Central Nervous System Involvement at Diagnosis or Relapse
Enrollment Status: Completed
Publish Date: December 10, 2024
Intervention Type: Drug
Study Drug: High-Dose Sequential Chemotherapy and Autologous Transplant
Study Phase: Phase 2
A Phase II Trial of Allogeneic Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Antifungal Prophylaxis With Posaconazole.
A Phase II Trial of Allogeneic Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Antifungal Prophylaxis With Posaconazole.
Enrollment Status: Completed
Publish Date: July 19, 2022
Intervention Type: Drug, Procedure
Study Drugs: GvHD Prophylaxis, Primary Antifungal Prophylaxis"
Study Phase: Phase 2
Treosulfan and Total-marrow Irradiation (TMI) Based Conditioning With Rapamycin Based Graft vs. Host Disease (GvHD) Prophylaxis for Allogenic Stem Cell Transplantation (Allo-HSCT) in Patients With High-risk Hematological Malignancies
Treosulfan and Total-marrow Irradiation (TMI) Based Conditioning With Rapamycin Based Graft vs. Host Disease (GvHD) Prophylaxis for Allogenic Stem Cell Transplantation (Allo-HSCT) in Patients With High-risk Hematological Malignancies
Enrollment Status: Terminated
Publish Date: October 19, 2020
Intervention Type: Procedure, Drug
Study Phase: Phase 1
View 2 Less Clinical Trials

64 Total Publications

CC486 as a safe and effective bridge to transplant in MDS-del5q with transfusion-dependent anemia following lenalidomide relapse: A case report.
CC486 as a safe and effective bridge to transplant in MDS-del5q with transfusion-dependent anemia following lenalidomide relapse: A case report.
Journal: Current research in translational medicine
Published: May 26, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Assanelli's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 26 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile